September 2021 Volume 17, Issue 9

september-issue-image

Volume 17, Issue 9 | September 2021

September 2021

In this Issue

Editor's Focus

A depiction of lungs in blue to the left of a SARS-CoV-2 virion in red.

The complex relationship between asthma and COVID-19

Respiratory viruses are the most common cause of asthma attacks, but COVID-19 does not send asthma patients to the hospital more often than others. Some researchers suspect that having asthma may actually protect patients from severe COVID-19.
A watercolor painting depicts a red and blue building with a clothesline hanging above and trees interspersed.

Prescribing art therapy for Parkinson's disease

Art therapy improved brain connectivity in patients with Parkinson’s disease, suggesting that creating art may help treat it and other neurodegenerative diseases.

Infectious Disease

Portrait of young sick man using nasal drops for runny congested nose.

A nasal spray for COVID-19

Experiments in ferrets show that a prophylactic spray cuts SARS-CoV-2 replication by more than 90 percent by priming the innate immune system.
istock-594921892-1800x900-compressed

Using CRISPR for disease eradication

Researchers employ CRISPR technology in a variety of creative ways to control the spread of vector-borne illnesses.

Hematology

Gray cells under a microscope with a few stained purple

A new initiative for developing autologous stem cell therapies

A biopharmaceutical company established a new method for isolating and editing hematopoietic stem cells from patients to provide stem cell therapies for diseases such as sickle cell disease.
Two women scientists in lab coats look up at a 96 well plate

CAR T cell therapy gives glioblastoma patients hope

Christine Brown develops CAR T cell therapies that may one day provide a long-sought-after cure for malignant brain cancers.
rub101-still002

Genetically-engineered red blood cells help train T cells to fight tumors 

New technology turns red blood cells into artificial antigen-presenting cells. These cells activate T cells to attack HPV-driven cancers.

Editors Insight

A lone flower grows up from the dirt.

Resiliency in science

Through research experience, scientists develop a strong sense of resiliency. The COVID-19 pandemic put that resiliency to the test, and now as vaccination rates increase and communities begin to open up, it’s time to take a breath.

Stem Cells

A 3D rendering of neurons shown as blue spindles.

Stem cells jump-start the brain after a stroke

Transplanted astrocyte precursor cells promote healing in mouse brains after strokes.
Axion Biosystems

A mind for medicine

Researchers are tapping into the regenerative power of stem cells to treat central nervous system disorders.

Aging

Telomeres (in white) cap the ends of chromosomes (in gray) and protect them from degradation.

Telomerase: the Protector of Chromosomes

Scientists found evidence of telomeres in the 1930s, but did not identify them until the 1970s. Since then, researchers’ understanding of telomeres and their role in DNA repair, aging, and disease has expanded exponentially.
A neon blue outline of a brain with multicolor starlight resembling space on a faded blue network background.

Traveling to new frontiers: Antibody therapy for neurodegenerative diseases

Scientists leverage the natural ability of antibodies to cross the blood-brain barrier and target proteins implicated in neurodegenerative disease.
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Gold circles with attached purple corkscrew shapes represent gold nanoparticles against a black background.

Driving gene therapy with nonviral vectors 

Learn why nonviral vectors are on the rise in gene therapy development.
A 3D digital illustration of a viral spike protein on a cell surface, surrounded by colorful, floating antibodies in the background

Milestone: Leapfrogging to quantitative, high throughput protein detection and analysis

Researchers continuously push the boundaries of what’s possible with protein analysis tools.
Blue cancer cells attached to a cellular surface against a bright blue background in a 3D rendering of a cancer infection.

Advancing immuno-oncology research with cellular assays

Explore critical insights into immunogenicity and immunotoxicity assays for cancer therapies.
Drug Discovery News November 2024 Issue
Latest IssueVolume 20 • Issue 6 • November 2024

November 2024

November 2024 Issue

Explore this issue